cathepsin L inhibitors (Phelix Therapeutics)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecathepsin L inhibitors (Phelix Therapeutics)
Drug Alias Namepan-anticoronavirus inhibitors (Phelix Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin L inhibitors
TargetsCathepsin L
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhelix Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhelix Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A